Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Alcohol Use DisorderHivTobacco Use Disorder

Interventions

DRUG

Varenicline

All participants will receive a prescription for varenicline and will meet with a clinical pharmacist and addiction psychiatrist for further support

Trial Locations (1)

RECRUITING

Atlanta VA Medical Center, Decatur

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT06006143 - Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 | Biotech Hunter | Biotech Hunter